CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 28, 2014--
AVEO Oncology (NASDAQ:AVEO) today announced that Tuan Ha-Ngoc, chief
executive officer, is scheduled to present at the Jefferies Global
Healthcare Conference on Thursday, June 5, 2014 at 8:30AM (ET) in New
A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com.
A replay of the webcast will be archived on the AVEO website for two
weeks following the presentation.
AVEO Oncology (NASDAQ: AVEO) is a biopharmaceutical company committed to
discovering and developing targeted therapies designed to provide
substantial impact in the lives of people with cancer by addressing
unmet medical needs. AVEO’s proprietary Human Response Platform™
provides the company with unique insights into cancer and related
disease biology and is being leveraged in the discovery and clinical
development of its therapeutic candidates. For more information, please
visit the company’s website at www.aveooncology.com.
Source: AVEO Oncology
Rob Kloppenburg, 617-299-5992